Shaeffer J R
Center for Blood Research, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
J Biol Chem. 1988 Sep 25;263(27):13663-9.
beta-Thalassemia is an inherited human disorder which is characterized by a deficient production of hemoglobin beta chains and an attendant accumulation of structurally normal alpha chains in the erythropoietic cells. The objective of this work is to understand the mechanism of intracellular proteolysis of these excess alpha chains. Dialyzed stroma-free hemolysates (32 mg/ml hemoglobin) of blood reticulocytes from four individuals with beta-thalassemia intermedia were incubated with human hemoglobin 3H-alpha chains (0.13 mg/ml) at 37 degrees C in a reaction mixture supporting protein degradation. In the presence of ATP and an ATP-generating system, the fraction of alpha chain 3H radioactivity made acid-soluble after 4 h ranged from 4 to 12% among the different hemolysates; in the absence of ATP or when hemolysates of normal human erythrocytes were used, only 1 to 2% of the 3H-alpha chains were degraded. It is likely that the ATP-dependent proteolysis of 3H-alpha chains in the beta-thalassemic hemolysates corresponds to the ATP-dependent turnover of newly synthesized soluble alpha chains in intact beta-thalassemic reticulocytes observed previously (Shaeffer, J. (1983) J. Biol. Chem. 258, 13172-13177) because of the following similarities between the two systems: (a) free 3H-alpha chains, but not 3H-labeled tetrameric hemoglobins, were readily degraded; (b) the rate of 3H-alpha chain proteolysis in the cell-free system was at least one-half of that observed for the turnover of newly synthesized alpha chains (t1/2 approximately 6 h) in intact cells; and (c) the ATP-dependent proteolytic activity of both systems was inhibited substantially by certain chemical agents (orthovanadate, N-ethylmaleimide, o-phenanthroline, and phenylmethylsulfonyl fluoride) but only slightly, if at all, by others (epsilon-aminocaproic acid and leupeptin). When excess human erythrocyte ubiquitin was added to the beta-thalassemic cell-free systems, a stimulation in ATP-dependent proteolysis of 3H-alpha chains ranging from 30 to 58% was observed. Conversely, addition of from 1.25 to 2.50 mg/ml affinity-purified rabbit antiubiquitin inhibited almost all (greater than 90%) of the ATP-dependent 3H-alpha chain proteolysis; in control experiments, antiubiquitin neutralized with excess ubiquitin inhibited only 13 to 30% of the total (including ubiquitin-stimulated) ATP-dependent proteolysis.(ABSTRACT TRUNCATED AT 400 WORDS)
β-地中海贫血是一种人类遗传性疾病,其特征是血红蛋白β链生成不足,以及在造血细胞中伴随出现结构正常的α链堆积。这项工作的目的是了解这些过量α链的细胞内蛋白水解机制。将来自四名中间型β-地中海贫血患者的血液网织红细胞的透析无基质溶血产物(血红蛋白浓度为32mg/ml)与人血红蛋白3H-α链(0.13mg/ml)在37℃下于支持蛋白质降解的反应混合物中孵育。在ATP和ATP生成系统存在的情况下,4小时后不同溶血产物中α链3H放射性变为酸溶性的比例在4%至12%之间;在没有ATP的情况下或使用正常人红细胞的溶血产物时,只有1%至2%的3H-α链被降解。β-地中海贫血溶血产物中3H-α链的ATP依赖性蛋白水解可能对应于先前在完整的β-地中海贫血网织红细胞中观察到的新合成可溶性α链的ATP依赖性周转(谢弗,J.(1983年)《生物化学杂志》258,13172 - 13177),因为这两个系统有以下相似之处:(a)游离的3H-α链,而不是3H标记的四聚体血红蛋白,容易被降解;(b)无细胞系统中3H-α链的蛋白水解速率至少是完整细胞中新合成α链周转速率(半衰期约6小时)的一半;(c)两个系统的ATP依赖性蛋白水解活性都被某些化学试剂(原钒酸盐、N-乙基马来酰亚胺、邻菲罗啉和苯甲基磺酰氟)显著抑制,但被其他试剂(ε-氨基己酸和亮肽素)抑制程度很小或根本不被抑制。当向β-地中海贫血无细胞系统中加入过量的人红细胞泛素时,观察到3H-α链的ATP依赖性蛋白水解有30%至58%的刺激作用。相反,加入1.25至2.50mg/ml亲和纯化的兔抗泛素几乎抑制了所有(大于90%)的ATP依赖性3H-α链蛋白水解;在对照实验中,用过量泛素中和的抗泛素仅抑制了总ATP依赖性蛋白水解(包括泛素刺激的)的13%至30%。(摘要截短至400字)